Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?
Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disorder of the central nervous system (CNS). Although many advances have been made in the comprehension of its pathogenesis, the etiology is still unknown. The complexity of MS reflects in the extreme variability of the clinical...
Main Authors: | Salvatore Monaco, Maria Donata Benedetti, Gianluigi Zanusso, Alberto Gajofatto, Matilde Bongianni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/12/11/7960/ |
Similar Items
-
Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2022-07-01) -
CSF and serum total-tau and phospho-tau(181P) in MS patients
by: Jaworski Jacek, et al.
Published: (2011-04-01) -
14-3-3 proteins—a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer’s disease
by: Gholamareza Abdi, et al.
Published: (2024-02-01) -
Pilot Study of the Total and Phosphorylated Tau Proteins in Early-Stage Multiple Sclerosis
by: Ieva Masiulienė, et al.
Published: (2024-02-01) -
Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
by: Rocco Cerroni, et al.
Published: (2020-06-01)